This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Now, if ever there ...
September 16, 2009 — Cancer therapies are increasingly being tailored to fit the genetic profile of the patient, but new research suggests that human epidermal growth-factor receptor (HER)2 gene ...
Ciombor estimated that 1 in 5 patients has metastatic disease at the time of diagnosis. Some 50% of patients with stage III disease who receive surgery alone eventually have a recurrence; the addition ...
Testing prioritization and frequency are highlighted in Dr Ciombor’s final insights for this HER2 biomarker focus. Kristen Ciombor, MD: HER2 amplification in metastatic colorectal cancer is typically ...
CHICAGO--(BUSINESS WIRE)--Tempus, a leader in artificial intelligence and precision medicine, announced new testing solutions to help physicians identify patients with HER2 or FOLR1 expressing tumors, ...
Dr. Angie DeMichele and Dr. Lynn Henry present the latest rapid recommendation impacting two ASCO guidelines. This update focuses on testing for ESR1 mutations in patients with hormone ...
HER2-positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (HER2), which promotes the growth of cancer cells. In about 1 of every ...
Please provide your email address to receive an email when new articles are posted on . Researchers developed a highly sensitive, analytic, quantitative ...
IRVINE, Calif.--(BUSINESS WIRE)--Genomic Testing Cooperative, LCA (GTC) announced that it will be presenting data at the 2023 American Association of Cancer Research (AACR) Annual Meeting ...
Correlation of disease-free survival at 2 to 3 years and 5-year overall survival in patients with muscle-invasive bladder cancer undergoing radical cystectomy. Influence of age and socioeconomic ...
Hosted on MSN
Olivia Munn’s Mom Diagnosed With HER2 Breast Cancer, Credits Risk Assessment Test for Early Diagnosis
Olivia Munn has come a long way with her personal experience of breast cancer. Having informed the world of her diagnosis in 2023, her update also brought awareness to her family, which is also ...
At the American Society of Clinical Oncology (ASCO) annual meeting, researchers reported on a multicenter, phase II trial exploring the efficacy and safety of adding pembrolizumab (Keytruda) to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback